Viewing nowEprasol Tablets 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

MFDS item code 201603584 · Approved 2016.06.20 · Insurance code 670401160
Treatment of acid-related disorders (including reflux and ulcers), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease and erosive esophagitis, as well as for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It is also effectively used in combination with antibiotics for the treatment of duodenal and peptic ulcers caused by Helicobacter pylori infection. It helps in the short-term treatment of gastrointestinal symptoms associated with non-steroidal anti-inflammatory drugs and in the treatment and prevention of gastric and duodenal ulcers occurring in patients taking NSAIDs. Additionally, it is suitable for the treatment of Zollinger-Ellison syndrome, as well as for the prevention and maintenance therapy for rebleeding of gastric or duodenal ulcers. This medication is beneficial in managing various gastrointestinal diseases.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended to control recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) treatment - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into two doses. 6) Maintenance therapy following initiation of intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following initiation of intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended to control recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 3. Children under 12 years of age There is no experience with administering this medicine to children under 12 years of age.
This medication should not be used in certain patients. For example, patients who are allergic or have experienced hypersensitivity reactions to this medication or its ingredients, as well as patients with allergies to penicillin or macrolide antibiotics should refrain from taking this medication. Furthermore, patients currently taking certain medications, such as terfenadine, cisapride, pimodivir, astemizole, atazanavir, nelfinavir, or rilpivirine-containing preparations should also avoid using this medication. Women who are nursing or patients with a history of myocardial infarction should not be administered this medication. This medication contains a dye called Yellow No. 5, so it should be used with caution in individuals with allergies or hypersensitivity to this component. When taking this medication, various side effects may occur, so caution is necessary. Commonly reported side effects include headache, abdominal pain, diarrhea, nausea, and vomiting, while rare cases of blood disorders, liver function abnormalities, and severe skin reactions have been reported. Regular check-ups are necessary during prolonged use, and patients should consult their physician if symptoms change. This medication can interact with other drugs, especially when taken simultaneously with antiviral agents, anticoagulants, antibiotics, and anticonvulsants. If pregnant or nursing, it is essential to consult a doctor regarding the use of this medication. In case of overdose, since no specific antidote exists, immediate medical attention is required.
Leukopenia, thrombocytopenia, agranulocytosis, hypersensitivity reaction, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, delirium, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, decreased appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonicity, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorder, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular eruption, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the effectiveness of the medication.
Pale pink, rectangular film-coated tablet
14 tablets (7 tablets / PTP packaging x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.